Status: current, Defined. Date: 28-Feb 2022. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4672381000168113 | risankizumab 150 mg / 1 mL injection, 1 mL pen device (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4672391000168111 | risankizumab 150 mg/mL injection, pen device | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
risankizumab 150 mg/mL injection, pen device | Is a | risankizumab | true | Inferred relationship | Some | ||
risankizumab 150 mg/mL injection, pen device | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
risankizumab 150 mg/mL injection, pen device | has manufactured dose form | injection | true | Inferred relationship | Some | ||
risankizumab 150 mg/mL injection, pen device | has unit of use | pen device | true | Inferred relationship | Some | 2040055774 | |
risankizumab 150 mg/mL injection, pen device | has intended active ingredient | risankizumab | true | Inferred relationship | Some | 1279208269 | |
risankizumab 150 mg/mL injection, pen device | has Australian BoSS | risankizumab | true | Inferred relationship | Some | 1279208269 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Skyrizi 150 mg/mL injection, 1 mL pen device | Is a | True | risankizumab 150 mg/mL injection, pen device | Inferred relationship | Some | |
risankizumab 150 mg/mL injection, 1 mL pen device | has MPUU | True | risankizumab 150 mg/mL injection, pen device | Inferred relationship | Some | 143687355 |
Reference Sets
Medicinal product unit of use reference set